Skip to main content
FinSpry Logo
FinSpry
TNGX logo
TNGX
(NASDAQ)
Tango Therapeutics, Inc.
$21.63-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Tango Therapeutics (TNGX) Stock Price & Financial Analysis

Tango Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$20.62 - $22.20
52-Week High$21.82
52-Week Low$1.03
Open$21.26
Volume2.91M
Average Volume (3M)2.91M
Market Cap2.51B
Shares Outstanding116.17M
Price to Sales (P/S)39.51
Price to Book (P/B)7.12
EV/EBITDA-21.89
Revenue (TTM)62.38M
Net Income (TTM)-101.59M
Free Cash Flow (TTM)-139.93M
EPS (TTM)$-0.87
Profit Margin-162.85%
Operating Margin-178.39%
Return on Equity (ROE)-29.35%
Debt to Equity0.10
50-Day MA$14.75
200-Day MA$9.53
52-Week Change1557.81%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tango Therapeutics

What is the current stock price for TNGX?

As of the latest trading session, TNGX stock trades at $21.63. The 52-week range is $1.03–$21.82, with a day range of $20.62–$22.20.

What is the P/E ratio for TNGX?

The P/E ratio (Price-to-Earnings) for TNGX is shown in the Key Statistics section. This valuation metric helps compare Tango Therapeutics, Inc. to industry peers.

Does TNGX pay dividends?

Tango Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TNGX?

Based on 7 analysts, the consensus for TNGX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TNGX?

Tango Therapeutics's market capitalization is $2.51B, classifying it as a mid-cap company. Tango Therapeutics operates in the Healthcare sector within the Biotechnology industry.